Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Public ClinicalTrials.gov record NCT01878292. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy, safety, and tolerability of vilazodone relative to placebo in adolescent outpatients (12-17) with major depressive disorder.
Study identification
- NCT ID
- NCT01878292
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 529 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 10, 2013
- Primary completion
- Mar 16, 2016
- Completion
- Oct 4, 2016
- Last update posted
- Dec 23, 2019
2013 – 2016
United States locations
- U.S. sites
- 52
- U.S. states
- 26
- U.S. cities
- 49
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site 073 | Imperial | California | 92251 | — |
| Forest Investigative Site 052 | Los Angeles | California | 90027 | — |
| Forest Investigative Site 023 | Murrieta | California | 92562 | — |
| Forest Investigative Site 004 | Orange | California | 92868 | — |
| Forest Investigative Site 037 | San Diego | California | 92108 | — |
| Forest Investigative Site 006 | Washington D.C. | District of Columbia | 20010 | — |
| Forest Investigative Site 039 | Gainesville | Florida | 32607 | — |
| Forest Investigative Site 009 | Jacksonville Beach | Florida | 32250 | — |
| Forest Investigative Site 063 | Miami | Florida | 33155 | — |
| Forest Investigative Site 034 | Oakland Park | Florida | 33334 | — |
| Forest Investigative Site 016 | Orlando | Florida | 32803 | — |
| Forest Investigative Site 064 | Orlando | Florida | 32806 | — |
| Forest Investigative Site 014 | Atlanta | Georgia | 30308 | — |
| Forest Investigative Site 030 | Roswell | Georgia | 30076 | — |
| Forest Investigative Site 032 | Libertyville | Illinois | 60048 | — |
| Forest Investigative Site 048 | Naperville | Illinois | 60563 | — |
| Forest Investigative Site 051 | Terre Haute | Indiana | 47802 | — |
| Forest Investigative Site 013 | Overland Park | Kansas | 66211 | — |
| Forest Investigative Site 070 | Lake Charles | Louisiana | 70629 | — |
| Forest Investigative Site 050 | Baltimore | Maryland | 21205 | — |
| Forest Investigative Site 054 | Baltimore | Maryland | 21208 | — |
| Forest Investigative Site 049 | Rockville | Maryland | 20852 | — |
| Forest Investigative Site 026 | Watertown | Massachusetts | 02472 | — |
| Forest Investigative Site 024 | Rochester Hills | Michigan | 48307 | — |
| Forest Investigative Site 015 | Creve Coeur | Missouri | 63141 | — |
| Forest Investigative Site 055 | Saint Charles | Missouri | 63304 | — |
| Forest Investigative Site 072 | St Louis | Missouri | 63128 | — |
| Forest Investigative Site 066 | Las Vegas | Nevada | 89128 | — |
| Forest Investigative Site 007 | Cherry Hill | New Jersey | 08002 | — |
| Forest Investigative Site 071 | Neptune City | New Jersey | 07752 | — |
| Forest Investigative Site 008 | Albuquerque | New Mexico | 87109 | — |
| Forest Investigative Site 057 | Rochester | New York | 14618 | — |
| Forest Investigative Site 059 | Durham | North Carolina | 27705 | — |
| Forest Investigative Site 053 | Avon Lake | Ohio | 44012 | — |
| Forest Investigative Site 021 | Canton | Ohio | 44718 | — |
| Forest Investigative Site 012 | Cincinnati | Ohio | 45219 | — |
| Forest Investigative Site 029 | Columbus | Ohio | 43210 | — |
| Forest Investigative Site 018 | Oklahoma City | Oklahoma | 73103 | — |
| Forest Investigative Site 011 | Oklahoma City | Oklahoma | 73112 | — |
| Forest Investigative Site 065 | Tulsa | Oklahoma | 74104 | — |
| Forest Investigative Site 040 | Philadelphia | Pennsylvania | 19139 | — |
| Forest Investigative Site 074 | Charleston | South Carolina | 29407 | — |
| Forest Investigative Site 062 | Memphis | Tennessee | 38119 | — |
| Forest Investigative Site 001 | Dallas | Texas | 75235 | — |
| Forest Investigative Site 027 | Houston | Texas | 77098 | — |
| Forest Investigative Site 041 | Plano | Texas | 75093 | — |
| Forest Investigative Site 045 | The Woodlands | Texas | 77381 | — |
| Forest Investigative Site 019 | Clinton | Utah | 84015 | — |
| Forest Investigative Site 060 | Richmond | Virginia | 23230 | — |
| Forest Investigative Site 035 | Bellevue | Washington | 98007 | — |
| Forest Investigative Site 068 | Bothell | Washington | 98011 | — |
| Forest Investigative Site 022 | Kirkland | Washington | 98033 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01878292, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 23, 2019 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01878292 live on ClinicalTrials.gov.